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Latent membrane protein 2A (LMP2A) is expressed in latent Epstein–Barr virus (EBV) infection. LMP2A functions to
downregulate B-cell signal transduction and viral reactivation from latency in EBV-immortalized B cells in vitro, and acts to
provide B cells with both a survival and developmental signal in vivo. Identification of proteins associated with LMP2A is
important for elucidation of the mechanism that LMP2A employs to regulate B-cell signal transduction and EBV latency.
LMP2A is constitutively tyrosine phosphorylated and is associated with protein tyrosine kinases such as Lyn and Syk when
specific LMP2A tyrosines are phosphorylated. The amino-terminal domain of LMP2A includes multiple proline-rich regions,
which may provide binding sites for proteins containing SH3 or WW domains. In this study, we demonstrate that four cellular
proteins bind specifically to two PPPPY (PY) motifs present within the LMP2A amino-terminal domain. Protein microsequence
analysis determined that three of these proteins were AIP4, WWP2/AIP2, and Nedd4. All of these proteins are members of
the Nedd4-like ubiquitin-protein ligases family and have conserved domains including the C2, WW, and ubiquitin-protein
ligase domain. The mutation of both PY motifs completely abolished binding activity of these proteins to LMP2A and the
interaction of AIP4 and WWP2 with LMP2A was confirmed in cell lines expressing LMP2A, WWP2, and AIP4. Furthermore,
a reduction in the level of Lyn and the rapid turnover of LMP2A and Lyn were observed in LMP2A-expressing cells. These
findings suggest that LMP2A recruits Nedd4-like ubiquitin-protein ligases and B-cell signal transduction molecules, resulting
in the degradation of LMP2A and Lyn by a ubiquitin-dependent mechanism. This provides a new means by which LMP2A may
modulate B-cell signal transduction. © 2000 Academic PressINTRODUCTION
EBV, a potentially oncogenic herpesvirus persisting in
B-lymphocytes of most adult humans, causes infectious
mononucleosis and is associated with a variety of he-
matopoietic cancers, such as African Burkitt’s lymphoma,
Hodgkin’s diseases, and adult T-cell leukemia (Kieff,
1996; Rickinson and Kieff, 1996; Longnecker, 1998). B-
lymphocytes infected with EBV in vitro are immortalized
and are termed lymphoblastoid cell lines (LCLs) (Kieff,
1996; Rickinson and Kieff, 1996; Longnecker, 1998).
These EBV-transformed LCLs express a restricted set of
latency-associated gene products, including six nuclear
proteins (EBNAs), three integral membrane proteins
(LMP1, 2A, and 2B), and two small RNAs (EBERs) (Kieff,
1996; Longnecker, 1998). However, in peripheral B-lym-
phocytes, mRNAs have been detected only for LMP2A,
EBNA1, and most recently the BARTs (Qu and Rowe,
1992; Tierney et al., 1994; Chen et al., 1995; Miyashita et
l., 1995; Miyashita et al., 1997; Chen et al., 1999). In
addition, EBNA1, LMP1, and LMP2A are the proteins
consistently detected in NPC tumor biopsies and EBV-
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178related malignancies in normal human hosts and im-
mune-compromised patients (Ambinder and Mann, 1994;
Rickinson and Kieff, 1996; Thorley-Lawson et al., 1996).
Thus, LMP2A may have important roles in vivo for viral
latency and persistence.
The outcomes of B-cell antigen-specific responses as
well as B-cell developmental responses are mediated by
signal transduction through B-cell receptor (BCR) (De-
Franco, 1993; Cambier et al., 1994; Rajewsky, 1996). In
primary B-lymphocytes, BCR stimulation leads to signal
cascades, including the recruitment and activation of
cellular protein tyrosine kinases, mobilization of intracel-
lular calcium, and transcription of BCR signal-specific
genes (DeFranco, 1993; Cambier et al., 1994). However,
in B cells latently infected with EBV, these signal cas-
cades are blocked. One EBV gene product, LMP2A, is
responsible for this phenotype (Miller et al., 1993,
1994a,b, 1995).
LMP2A contains a 119-amino-acid cytoplasmic amino-
terminus, 12 hydrophobic transmembrane domains, and
a 27-amino-acid cytoplasmic carboxyl-terminus and is
expressed in aggregates in the plasma membrane of
latently infected B cells (Longnecker and Kieff, 1990).
Most of the antiphosphotyrosine (APT) reactivity within
these B cells is associated with these LMP2A aggre-
gates (Longnecker and Kieff, 1990; Longnecker et al.,
1991). The amino-terminal domain of LMP2A has been
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179LMP2A PY MOTIF-INTERACTING PROTEINshown to be tyrosine phosphorylated and is necessary
for LMP2A association with the protein tyrosine kinases
Lyn and Syk, resulting in negative regulation of B-cell
signal transduction and the EBV lytic cycle (Burkhardt et
al., 1991; Longnecker et al., 1991; Miller et al., 1993,
1994a,b, 1995). Membrane aggregates of constitutively
phosphorylated LMP2A mimic activated receptor com-
plexes, competing for Src homology 2 (SH2) domain
containing proteins such as Lyn and Syk, thereby pre-
venting normal BCR signal transduction in EBV-infected
LCLs grown in tissue culture. In vivo, LMP2A expression
results in BCR-negative lymphocytes in peripheral or-
gans without elimination by apoptosis, which indicates
LMP2A provides both a development and survival signal
to normal B-cell lymphocytes (Caldwell et al., 1998).
The amino-terminal domain of LMP2A contains multi-
ple proline-rich regions, which are conserved in different
EBV clinical isolates and in the EBV-related herpesvirus
papio (Busson et al., 1995; Franken et al., 1995). These
regions may bind proteins containing SH3 or WW do-
mains. SH3 domains bind preferentially to prolines sep-
arated by two amino acids (PXXP) (Feng et al., 1994; Lim
et al., 1994). There are a total of five such sites within the
amino-terminal domain of LMP2A. Two of the proline-rich
regions (PPPPY) are homologous to PY motifs (XPPXY),
which interact with WW domains (Sudol, 1996). WW do-
mains bind to the central prolines of the PY motif only
when tyrosine residue is not phosphorylated. To investi-
gate whether the LMP2A proline-rich regions might in-
teract with either SH3 or WW domains, nonphosphory-
lated LMP2A was expressed in bacteria as a GST fusion
protein. Four cellular proteins bound to the LMP2A GST
fusion protein. Mutation of the two central prolines of the
PY motifs of LMP2A was found to abrogate binding of the
cellular proteins, whereas mutation of any of the poten-
tial SH3 binding sites did not affect binding of the cellular
proteins. Microsequence analysis of the LMP2A-associ-
ated proteins identified them as members of the Nedd4
ubiquitin-protein ligase family, all of which contain WW
domains. The mutational analysis was consistent with
the cellular proteins associating to the LMP2A PY motif
by a WW–PY motif interaction.
Members of an emerging family of proteins related to
Nedd4 have a unique modular structure consisting of a
C2 domain (Ca21-dependent phospholipid-binding), mul-
tiple WW domains, and a ubiquitin-protein ligase domain
(Harvey and Kumar, 1999). The ubiquitin-dependent pro-
teolysis system is characterized by the covalent ligation
of multiple ubiquitin peptides to target proteins, which
serves as a signal for recognition and degradation by the
26S proteasome (Ciechanover, 1994; Hochstrasser,
1996). The ubiquitin-protein ligase domain was first
found in the non-Nedd4-like protein, human E6-associ-
ated protein (E6-AP), and designated as a HECT (homol-
ogous to E6-AP C-terminus) domain. E6-AP specifically
binds to human papillomavirus (HPV) E6 oncoprotein.
t
tThe resulting complex binds p53, which results in the
rapid ubiquitin-dependent degradation of p53 and the
interference with the negative-growth regulatory function
of p53 (Huibregtse et al., 1991, 1993a,b; Scheffner et al.,
1993). Nedd4 interacts with an epithelial sodium channel
(ENaC), which is composed of three subunits (abg), each
ontaining a proline-rich region regulated by ubiquitina-
ion (Staub et al., 1997). Liddle’s syndrome in humans, a
ereditary form of hypertension, is caused by deletions
r mutations within the PY motifs of b or g ENaC, which
lead to an inhibition of Nedd4 binding (Shimkets et al.,
1994; Hansson et al., 1995a,b; Staub et al., 1996; Tamura
t al., 1996).
In this study, we have shown that the two highly con-
erved PY motifs in the amino-terminal domain of LMP2A
re associated with the three human Nedd4-like ubiq-
itin-protein ligases AIP4, WWP2, and Nedd4. Consider-
ng the important role of Nedd4-like proteins in regulat-
ng membrane channels, receptors, and transporters
hrough ubiquitination, LMP2A-associated ubiquitin-pro-
ein ligases may be important for the targeting of LMP2A-
ssociated proteins for degradation. In support of this
otion, the Lyn protein tyrosine kinase exhibited a dra-
atically reduced half-life in BJAB cells expressing
MP2A when compared to vector-control cells, and the
MP2A and Lyn proteins were also rapidly degraded
hen compared to other cellular proteins. These results
rovide tantalizing evidence that ubiquitin ligases are
ecruited to the LMP2A PY motifs, resulting in the ubiq-
itination of LMP2A and LMP2A-associated proteins
hich may play an important role for EBV latency and the
egulation of B-cell signal transduction.
RESULTS
he LMP2A PY motifs are essential for binding of a
10-kDa cellular protein
To identify proteins which bind to the nonphosphory-
ated LMP2A amino-terminus, bacterially expressed
MP2A GST fusion proteins were isolated and used as
n affinity matrix with 35S-labeled cellular extracts from
the EBV-negative B-lymphoma cell line BJAB. A cellular
protein of 110 kDa (p110) specifically bound to amino
acids 9–120 and 1–119 of the LMP2A amino-terminus
(Fig. 1C, lanes 2 and 3). This protein was not detected
when the GST fusion partner was used alone (Fig. 1C,
lane 1). To determine the LMP2A region responsible for
the binding of p110, a variety of LMP2A-GST fusion pro-
teins were constructed containing specific regions of
LMP2A or specific mutations in the LMP2A amino acid
sequence. First, four internal deletion mutants were con-
structed (Fig. 1B, D21–36, D21–64, D21–85, and D80–
12). In binding assays, each of the LMP2A-deletion
usion proteins bound p110 (Fig. 1C, lanes 4 to 7). Next,
hree nonoverlapping and two overlapping portions of
he LMP2A amino-terminus were fused to GST (Fig. 1B,
2A ami
180 IKEDA ET AL.1–39, 40–79, 80–119, 1–79, and 40–119) and examined in
binding assays (Fig. 1C). Of the three nonoverlapping
FIG. 1. Schematic representation of the LMP2A fusion proteins and
LMP2A amino-terminal domain. Proline-rich regions (P1 to P5) are in
indicated under LMP2A sequence. (B) LMP2A GST-fusion proteins. T
shown. Ability to bind p110 for each fusion construct is indicated at the
hyphens. Proline residues are indicated as open boxes and mutated al
GST fusion proteins were immobilized to glutathione–agarose and the
bound to the LMP2A-GST fusion proteins were separated on 8% SDS–PA
protein of approximately 110 kDa, which bound specifically to the LMP
are indicated at the left.GST fusion proteins, two (40–79 and 80–119) retained the
ability to bind to p110 (Fig. 1C, lanes 9 and 10), whereasthe fusion protein containing amino acids 1–39 was
unable to bind to p110 (Fig. 1C, lane 8). The two overlap-
nding activity using BJAB cellular lysates. (A) Amino acid sequence of
on the top of LMP2A sequence, and PY motifs (PY1 and PY2) are
vant LMP2A wild-type and mutant GST fusion protein constructs are
ith either a (1) or (2). Deleted amino acid residues are indicated as
are indicated as closed boxes. (C) GST binding assay. LMP2A mutant
ated with 35S-labeled BJAB lysates and extensively washed. Proteins
d the resulting autoradiographs are shown from dried gels. The cellular
no-terminus, is indicated by an arrow. Protein standards in kilodaltonstheir bi
dicated
he rele
right w
anines
n incub
GE anping fusion proteins containing amino acids 1–79 and
40–119 both retained p110 binding activity (Fig. 1C, lanes
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181LMP2A PY MOTIF-INTERACTING PROTEIN11 and 12). These results indicate that amino acids 40–79
or 80–119 of LMP2A were sufficient to interact with p110.
Analysis of the amino acid sequence of the LMP2A
amino-terminus revealed multiple proline-rich regions
that could bind cellular proteins by means of an SH3 or
WW domain interaction (Fig. 1A, P1–P5). Since p110 did
not bind to the first proline-rich region of LMP2A (Figs. 1A
and 1C, lane 8), the other four proline-rich regions were
mutated to distinguish between SH3 binding and WW
binding in the context of the two nonoverlapping LMP2A
GST fusion proteins. WW domain binding requires two
central prolines followed by any amino acid, then a
nonphosphorylated tyrosine (PPXY), whereas SH3 bind-
ing generally requires two prolines separated by two
amino acids (PXXP). A total of six different mutations
were engineered into the LMP2A fusion proteins. To
determine whether p110 was a WW domain-containing
protein which bound to LMP2A, the central prolines of
two PPPPY motifs were mutated to alanines (Fig. 1B,
P3-WW and P4-WW). To determine whether p110 con-
tained an SH3 domain that may bind to LMP2A, the
outermost prolines of the four PXXP motifs found in the
LMP2A amino-terminus were mutated to alanines (Fig.
1B, P2-SH3, P3-SH3, P4-SH3, and P5-SH3). Mutation of
the central prolines of either PPPPY motif completely
abolished binding of p110 to LMP2A (Fig. 1C, lanes 17
and 19), whereas mutation of any of the potential SH3
binding regions of LMP2A did not affect binding of p110
to LMP2A (Fig. 1C, lanes 15, 16, 18, and 20). Thus, it is
likely that p110 binds to LMP2A by a WW domain inter-
action with the central prolines of the LMP2A PY motif. To
confirm the LMP2A PY motifs are sufficient for p110
binding, mutations in PY motifs were incorporated into
the complete amino-terminus of LMP2A from amino ac-
ids 1–119 (Fig. 1B, PY1, PY2, and PY1PY2). Mutation of
either of the PPPPY motifs did not affect binding of p110
to LMP2A (Fig. 1C, lanes 23 and 24), whereas mutation of
both PPPPY motifs resulted in the complete absence of
binding of p110 to LMP2A (Fig. 1C, lane 25). These
results indicate, as did the results with the two nonover-
lapping LMP2A GST fusion proteins, that the LMP2A PY
motifs are binding sites for the cellular p110 protein.
LMP2A PY motif-associated proteins
To investigate p110 binding to LMP2A in other cell
lines, LMP2A binding assays were performed with vari-
ous cell lysates, which had been labeled with [35S]me-
hionine-cysteine. Both the full length LMP2A GST fusion
nd the LMP2A fusion protein incorporating mutations in
oth of the LMP2A PY motifs were tested. BJAB, Raji, and
amos are human B-cell lines. Jurkat and HPB.ALL are
uman T-cell lines. M12 is a mouse B-cell line. Four
ellular proteins in human and three cellular proteins in
ouse cell lines specifically associated with the wild-
ype LMP2A amino-terminus (Fig. 2, 1–119) but not when
L
che PY motifs were mutated (Fig. 2, PY1PY2). The bands
bserved in BJAB cells were designated I to IV. Band-I,
he most readily detected, was observed in all human
ell lysates. Band-III was most easily observed in cell
ysates from HPB.ALL cells, but was also evident in the
-cell extracts, but appeared to be absent in the murine
-cell lysate. Band-II and band-IV were not as readily
etected but were present in all cell lines. Band-IV was
he most abundant interacting protein with the LMP2A
usion protein in the murine B-cell lysates. None of the
ands was apparent when either the GST fusion partner
r the LMP2A fusion protein containing the mutants in
he two PY motifs was used in the binding reactions.
hese results indicate that LMP2A associates specifi-
ally with a potential family of proteins of approximately
10 to 118 kDa and this interaction requires the PY motifs
f LMP2A.
MP2A binds to WW domain-containing
biquitin-protein ligases
To identify the LMP2A PY motif-associated proteins,
and-I and band-III were purified from BJAB and
PB.ALL cells, respectively. Proteins were separated
n SDS–PAGE, excised from gel and digested proteo-
ytically. Peptides were analyzed by mass spectrome-
ry. The acquired mass spectra of the individual se-
uences were then correlated with known sequences.
total of 26 peptides were obtained from band-I; 20
eptides were matched to human AIP4, three peptides
ere matched to mouse Itchy, and four peptides were
atched to human WWP2/AIP2 (Table 1). These pro-
eins are highly homologous and contain a C2 domain,
W domains, and a ubiquitin-protein ligase domain
Fig. 3A). The presence of WW domains in these pro-
eins is consistent with the requirement of the LMP2A
Y motifs for binding to band-I. A full-length cDNA for
IP4 gene has not yet been isolated, thus the amino-
erminus of the AIP4 protein sequence has not been
etermined. Since Itchy is the mouse AIP4 homolog
nd is well conserved, some Itchy peptides were
atched to the corresponding AIP4 sequence, which
s not in the database. These results showed that AIP4
as the major protein in band-I, whereas WWP2 was
minor constituent of band-I or possibly a contami-
ant from band-II. A total of 35 peptides were obtained
rom the analysis of band-III (Table 1). A total of 33
eptides was derived from Nedd4, one peptide was
atched to AIP4, and one peptide was matched to
tchy. The Itchy peptide is derived from AIP4 as de-
cribed earlier. Sequence analysis has not yet been
btained for band-II and band-IV. In summary, the
equence analysis is compatible with an interaction of
MP2A with WW domain-containing proteins, which
omprise the Nedd4 ubiquitin-protein ligase family.
S
1 s, whic
o ted by
182 IKEDA ET AL.cDNA cloning of AIP4 and WWP2
Full-length cDNAs of AIP4 and WWP2 were isolated as
described under Materials and Methods. The AIP4 cDNA
contained a coding sequence of 864 amino acids and the
carboxyl-terminal portion of 739 amino acids was iden-
tical to the reported partial AIP4 sequence found in
GenBank (Fig. 3B). The WWP2 cDNA contained a coding
sequence of 870 amino acids, which was consistent with
the reported sequence. All peptides classified as Itchy by
microsequence analysis were identified in the amino-
terminal portion of AIP4, of which the sequence had not
been reported. The amino acid sequence of AIP4
showed 96% homology to Itchy, 57% homology to WWP2,
and 39% homology to human Nedd4. The common con-
served features of the Nedd4 family of ubiquitin-protein
ligases are shown in Fig. 3A, which include the C2
domain (Ohno et al., 1987) at the amino-terminus, WW
FIG. 2. LMP2A PY motif interacting proteins. The wild-type LMP2A1
(PY1PY2), or GST alone (GST) were incubated with 35S-labeled cell
DS–PAGE. The resulting autoradiogram of the dried gel is shown: BJA
2), HPB.ALL (lanes 13 to 15), and M12 (lanes 16 to 18). Cellular protein
f protein in the LMP2APY1PY2 mutant GST fusion protein, are indicadomains in the middle, and a HECT (Huibregtse et al.,
1995) domain at the carboxyl-terminus. The HECT do-main encodes the ubiquitinating activity, whereas the
binding specificity for target proteins is contained within
the WW and the C2 domains.
AIP4 and WWP2 bind LMP2A in vivo
To examine the in vivo interaction of LMP2A and
Nedd4-like ubiquitin-protein ligases, FLAG-tagged AIP4
and FLAG-tagged WWP2 expression vectors were con-
structed. Six different transfections were performed with
the vector control and the various expression constructs
followed by immunoprecipitations of cell lysates with HA
and FLAG antibodies. The immunoprecipitates were
probed in Western blots with either HA or FLAG antibod-
ies. The first set, shown in Fig. 4 (lanes 1–3), consisted of
the FLAG-tagged AIP4 and WWP2 along with the vector
control. As expected, both the FLAG-tagged AIP4 and
WWP2 were readily detected in FLAG blots of FLAG
ST fusion protein (1–119), the PY mutant LMP2A GST fusion protein
from a variety of cell lines, extensively washed, and separated by
es 1 to 3), Ramos (lanes 4 to 6), Raji (lanes 7 to 9), Jurkat (lanes 10 to
h specifically bound the LMP2A PY motifs as determined by absence
arrowheads. Protein standards in kilodaltons are indicated at the left.–119 G
lysates
B (lanimmunoprecipitations (Fig. 4B, lanes 2 and 3) and no
reactive proteins were detected in vector-alone transfec-
c
mTABLE 1
Microsequence Analysis of LMP2A PY Motif Interacting Proteinsa
Band Peptide Sequence Source Positionb
Band-I 1 PLNPVTQAPLPPGWEQR AIP4 (155–171)
2 TTWDRPEPLPPGWER AIP4 (188–202)
3 IYYVDHFTR AIP4 (210–218)
4 SQLQGAMQQFNQR AIP4 (241–253)
5 FIYGNQDLFATSQSK AIP4 (254–268)
6 EFDPLGPLPPGWEK AIP4 (269–282)
7 VYFVNHNTR AIP4 (290–298)
8 ITQWEDPR AIP4 (299–306)
9 SQGQLNEKPLPEGWEMR AIP4 (307–323)
10 FTVDGIPYFVDHNR AIP4 (324–337)
11 SALDNGPQIAYVR AIP4 (350–362)
12 TLFEDSFQQIMSFSPQDLR AIP4 (392–410)
13 LWVIFPGEEGLDYGGVAR AIP4 (413–430)
14 FIDTGFSLPFYK AIP4 (490–501)
15 ILNKPVGLK AIP4 (503–511)
16 DLESIDPEFYNSLIWVK AIP4 (512–528)
17 ENNIEECDLEMYFSVDKEILGEIK AIP4 (529–552)
18 SHDLKPNGGNILVTEENKEEYIR AIP4 (553–575)
19 LLQFVTGTCR AIP4 (663–672)c
20 LPVGGFADLMGSNGPQK AIP4 (673–689)
21 KNWFGPSPYVEVTVDGQSK Itchy (24–42)
22 NWFGPSPYVEVTVDGQSK Itchy (25–42)
23 WKQPLTVIVTPTSK Itchy (55–68)
24 NELLGTASVNLSNVLK WWP2 (93–108)
25 FIDTGFTLPFYK WWP2 (621–632)
26 AFLDGFNEVAPLEWLR WWP2 (723–738)
27 LLQFVTGTCR WWP2 (794–803)c
Band-III 1 KDILGASDPYVR Nedd4 (61–72)
2 DILGASDPYVR Nedd4 (62–72)
3 VTLYDPMNGVLTSVQTK Nedd4 (73–89)
4 LLFEVFDENR Nedd4 (114–123)
5 DDFLGQVDVPLYPLPTENPR Nedd4 (127–146)
6 DFVLHPRSHK Nedd4 (155–164)
7 TYYVNHESR Nedd4 (234–242)
8 RPTPQDNLTDAENGNIQLQAQR Nedd4 (248–269)
9 PTPQDNLTDAENGNIQLQAQR Nedd4 (249–269)
10 LTIFGNSAVSQPASSSNHSSR Nedd4 (332–352)
11 GSLQAYTFEEQPTLPVLLPTSSGLPPGWEEK Nedd4 (354–384)
12 HAPNGRPFFIDHNTK Nedd4 (458–472)
13 TTTWEDPR Nedd4 (473–480)
14 TQWEDPR Nedd4 (526–532)
15 LENVAITGPAVPYSR Nedd4 (533–547)
16 KYEFFR Nedd4 (552–557)
17 KQNDIPNKFEMK Nedd4 (562–573)
18 QNDIPNKFEMK Nedd4 (563–573)
19 RATVLEDSYR Nedd4 (576–585)
20 ATVLEDSYR Nedd4 (577–585)
21 LWIEFDGEK Nedd4 (600–608)
22 GLDYGGVAR Nedd4 (609–617)
23 DYGGVAR Nedd4 (611–617)
24 EWFFLISK Nedd4 (618–625)
25 VAGMAVYHGK Nedd4 (668–677)
26 MMLHKPITLHDMESVDSEYYNSLR Nedd4 (690–713)
27 WILENDPTELDLR Nedd4 (714–726)
28 FIIDEELFGQTHQHELK Nedd4 (727–743)
29 NGGSEIVVTNK Nedd4 (744–754)
30 NGYSANHQVIQWFWK Nedd4 (823–837)
31 AVLMMDSEK Nedd4 (838–846)
32 LLQFVTGTSR Nedd4 (850–859)
33 LDLPPYESFEELWDK Nedd4 (898–912)
34 FIYGNQDLFATSQSK AIP4 (254–268)
35 SQLQITVISAK Itchy (8–18)
a Band-I and band-III as shown in Fig. 2 were purified with the 1–119 amino acid LMP2A GST fusion protein from an 8-liter culture of BJAB and HPB.ALL
ells, respectively. Purified proteins were digested proteolytically and microsequenced by microcapillary reverse-phase HPLC nanoelectrospray tandem
ass spectrometry (mLC/MS/MS) on a Finnigan LCQ quadrupole iontrap mass spectrometer. Peptides correlated with known sequences are indicated.b Residue positions are from AIP4(AF038564), Itch(AF037454), WWP2(U96114), and Nedd4(D42055).
c A peptide corresponding to both AIP4 and WWP2/AIP2.
184 IKEDA ET AL.FIG. 3. Domain structure and amino acid alignment of the Nedd4-like ubiquitin ligases. (A) Schematic representation of the domains of the
Nedd4-like ubiquitin ligases. C2 domain (light gray boxes), WW domains (black boxes), and HECT domain (dark gray boxes) are indicated. The
undetermined amino-terminus of the human homolog of Nedd4 is indicated by wavy line. (B) Amino acid alignment of AIP4, WWP2, and mouse Itchy.
The full-length cDNA of AIP4 was isolated and the deduced amino-terminus of AIP4 was aligned with Itchy and WWP2, also known as AIP2.
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185LMP2A PY MOTIF-INTERACTING PROTEINtions (Fig. 4B, lane 1). As expected, no HA-reactive pro-
teins were present in HA immunoprecipitates when
probed with HA antibodies (Fig. 4A, lanes 1–3). Finally,
also as expected, no HA-reactive proteins were detected
in the FLAG immunoprecipitates when probed with HA
antibodies (Fig. 4C, lanes 1–3). In the second set of
transfections, the HA-tagged LMP2A was included to
explore the interaction of LMP2A with AIP4 and WWP2.
The 54-kDa LMP2A protein was readily detected when
cotransfected with the vector control or the FLAG-tagged
AIP4 and WWP2 expression constructs when lysates
were immunoprecipitated with HA antibodies, followed
by blotting for the HA tag (Fig. 4A, lanes 4–6). FLAG-
tagged AIP4 and WWP2 were also detected in the FLAG
immunoprecipitation, followed by blotting for the FLAG
tag (Fig. 4B, lanes 5 and 6). No FLAG-reactive proteins,
except for a background band, were detected in the
control transfection (Fig. 4B, lane 4). There was an ap-
parent reduction of both AIP4 and WWP2 when com-
pared to transfections when the LMP2A-expression con-
struct was omitted (Fig. 4B, compare lanes 2 and 5, and
lanes 3 and 6). This reduction was observed in multiple
experiments and suggests that LMP2A may influence the
Conserved amino acid residues are shaded. C2, WW, and HECT dom
cDNA, three methionine residues were identified that could serve as
revealed that none contained a perfect match for a Kozak sequence (Ko
sequences are conserved in the mouse Itchy gene. WWP2 contains a
of the AIP4 protein are 98674/97724/97235 for 862/852/847 amino acid
FIG. 4. Binding of LMP2A to AIP4 and WWP2 in BJAB cells trans-
fected with expression constructs. Cell lysates were prepared from
BJAB cells cotransfected with expression plasmids encoding FLAG-
AIP4, FLAG-WWP2, or pcDNA3.1 vector alone and expression plasmids
encoding LMP2A-HA or pSG5 vector alone and immunoprecipitated
with anti-FLAG antibody (M2) or anti-HA antibody (HA.11) as indicated.
Precipitated proteins were separated on SDS–PAGE and immunoblot-
ted with biotinylated anti-FLAG antibody (Bio M2) or anti-HA antibody
(HA.11), followed by incubation with NeutrAvidin-HRP or HRP-conju-
gated antimouse IgG antibody and ECL detection.870 amino acids of WWP2, and 107097 for 927 amino acids of Nedd4 contained
are smaller than the actual sizes on SDS–PAGE, the sizes are compatible withprotein stability of AIP4 and WWP2. Interestingly, LMP2A
was readily detected in the FLAG immunoprecipitations
when the immunoprecipitations were probed with HA
antibodies, indicating that LMP2A was able to associate
with either AIP4 or WWP2 when these proteins were
coexpressed in BJAB cells (Fig. 4C, lanes 5 and 6). No
HA-tagged LMP2A was detected in the control immuno-
precipitations, demonstrating the specificity of the inter-
action (Fig. 4C, lane 4). This experiment clearly indicates
that AIP4 and WWP2 bind to LMP2A in vivo.
Lyn is degraded in LMP2A-expressing cells
To investigate whether the interaction of the LMP2A
PY motifs with WW domain-containing ubiquitin-protein
ligases has functional significance, the half-life of Lyn
was investigated in different clonal BJAB cell lines ex-
pressing LMP2A. The Lyn protein tyrosine kinase has
previously been shown to bind to tyrosine 112 of the
LMP2A amino-terminus. In addition, previous studies
had observed reduced Lyn levels in EBV1LMP2A1 LCLs
when compared to EBV1LMP2A2 LCLs (Fruehling et al.,
998). The significance of these previous observations
as not fully appreciated, but in light of the current
bservations, it was apparent that a possible role of
MP2A in protein turnover should be investigated.
MP2A may recruit ubiquitin-protein ligases that may
arget LMP2A-associated proteins for degradation. To
irectly test this hypothesis, BJAB cells constitutively
xpressing LMP2A (LMP2A1) were constructed and half-
lives of Lyn were measured. Cells were pulse-labeled
with [35S]methionine-cysteine and collected at 4, 8, and
20 h postpulse. Labeled Lyn levels were evaluated by
immunoprecipitation with anti-Lyn antibody followed by
SDS–PAGE. Lyn-specific bands were quantitated by den-
sitometry of the resulting autoradiograms from dried gels
and the results are graphed in Fig. 5. For LMP2A-ex-
pressing cells, the half-life of Lyn was approximately 10 h
for two LMP2A-expressing cell lines, whereas in the third
LMP2A-expressing cell line, the Lyn half-life was approx-
imately 20 h (Fig. 5). The Lyn half-life in each of the
vector-control cell lines was significantly greater than
20 h (Fig. 5). These experiments demonstrate expression
of LMP2A in BJAB cells dramatically alters the half-life of
the LMP2A-associated protein Lyn, suggesting that
LMP2A may direct the ubiquitination of Lyn, which in turn
results in the degradation of Lyn.
To further investigate the turnover of Lyn and other
e underlined. From the deduced amino acid sequence from the AIP4
n translation start sites. Analysis of the surrounding DNA sequence
86) (Met1: GGTATGT; Met11: TCAATGG; and Met16: ACCATGA). These
ethionine which serves as its start site. Predicted molecular weights
4; 98992/97974/97484 for 864/854/849 amino acids of Itchy; 99068 forains ar
protei
zak, 19
single m
s of AIPin the partial Nedd4 cDNA. Although the calculated molecular weights
the location of the bands as determined by the mass spectral analysis.
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186 IKEDA ET AL.proteins that may be associated with LMP2A, cyclohex-
imide was used to block de novo protein synthesis in the
MP2A-expressing BJAB cells and vector-control cells.
he protein levels of LMP2A, Lyn, Syk, the p85 subunit of
I3-kinase, and tubulin were evaluated after addition of
ycloheximide. The level of each protein was determined
t time 0, 12, and 24 h postaddition of cycloheximide by
mmunoblotting with specific antibodies to each protein.
n control cells, the levels of each of the proteins re-
ained stable over the entire course of the experiment
Figs. 6A–6E). In LMP2A-expressing cells, both LMP2A
nd Lyn were rapidly degraded (Figs. 6A and 6B),
hereas the levels of Syk, the p85 subunit of PI3-kinase,
nd tubulin remained stable throughout the course of the
xperiment (Figs. 6C–6E). Moreover, the absolute level of
yn, which migrates as a doublet representing the p56
nd p53 forms of the protein generated by alternative
plicing, even at time 0, was dramatically lower in the
MP2A-expressing cell lines when compared to the vec-
or-control cell lines. These experiments verify that ex-
ression of LMP2A results in dramatic reduction in the
teady-state level of the Lyn protein tyrosine kinase and
lso in the rapid degradation of the Lyn protein tyrosine
inase. Interestingly, other LMP2A-associated proteins,
uch as the Syk protein tyrosine kinase, do not appear to
e degraded in LMP2A-expressing cell lines.
DISCUSSION
The results of the current study have identified a novel
ssociation of LMP2A with Nedd4-like ubiquitin-protein
FIG. 5. Half-life of Lyn in LMP2A-expressing BJAB cells. Cell lysates
were prepared from different clonal BJAB cell lines expressing LMP2A
(closed symbols: A10, C12, and F11) and different clonal control cells
(open symbols: A4, C1, and F6) at 0, 4, 8, and 20 h postpulse-labeling
with 35S. Labeled proteins were immunoprecipitated with anti-Lyn an-
ibody, separated on SDS–PAGE, and visualized by autoradiography.
he amount of Lyn was determined by densitometric analysis and
lotted as a relative ratio with the amount of Lyn in each cell line set at
at the 0 time point.igases through an interaction of the PY motifs contained
ithin the amino-terminal domain of LMP2A. This inter-ction is likely through the WW domains contained within
he family of Nedd4-like ubiquitin-protein ligases. In ad-
ition, we have demonstrated reduced protein half-life of
yn and the rapid turnover of LMP2A and Lyn in cell lines
xpressing LMP2A when compared to vector-control
ells. Taken together, these findings suggest that LMP2A
ecruits Nedd4-like ubiquitin-protein ligases, resulting in
he ubiquitination of LMP2A and LMP2A-associated pro-
eins such as Lyn. LMP2A-targeted degradation of Lyn
ay be an important first step in the modulation of B-cell
ignal transduction by LMP2A.
The PY motif was first described in WBP-1 and WBP-2,
hich were identified as ligands for WW domains in the
es-associate protein (YAP) (Chen and Sudol, 1995). The
Y motif is conserved in several unrelated proteins, in-
luding three epithelial sodium channel (ENaC) subunits,
iral Gag proteins, b-dystroglycan, atrophin-1, and sev-
ral transcription factors (Einbond and Sudol, 1996). WW
omains are protein–protein interaction modules found
n a variety of proteins, including a putative transmem-
rane protein CD45AP, the signal transducing factor
AP65, the cytoskeletal components dystrophin and utro-
hin, a family of Nedd4-like ubiquitin-protein ligases,
uclear proteins including Pin1/dodo, FE65, ESS1, and
ormin-binding proteins (FBPs) (Rotin, 1998). The biology
f the WW domain–PY motif interaction has been impli-
ated in several human genetic disorders, including Lid-
le’s syndrome (hereditary form of hypertension), mus-
ular dystrophy, Alzheimer’s disease, and also in retro-
irus budding and assembly (Bork and Sudol, 1994;
FIG. 6. Protein levels in the BJAB cells expressing LMP2A following
cycloheximide treatment. Whole-cell extracts were prepared from BJAB
cells expressing LMP2A (C12 and F11) and control cells (C1 and F6) at
0, 12, and 24 h postaddition of 0.1 mg/ml cycloheximide (CHX) to the
culture media. Immunoblot analysis was performed with (A) anti-
LMP2A; (B) anti-Lyn, which detects both the 56- and 53-kDa Lyn protein;
(C) anti-Syk; (D) anti-p85, which detects the 85-kDa subunit of PI3-
kinase; and (E) anti-Tubulin. The respective proteins are indicated by
arrows at the right of the figure.
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187LMP2A PY MOTIF-INTERACTING PROTEINEinbond and Sudol, 1996; Garnier et al., 1996; Staub et
al., 1996; Sudol, 1996).
Recently, many homologs of Nedd4 have been discov-
red. These include human/mouse/rat Nedd4, human
IP4, human WWP1/AIP5, human WWP2/AIP2, mouse
tchy, budding yeast Rsp5, and fission yeast Pub1 (Hof-
ann and Bucher, 1995; Nefsky and Beach, 1996; Pirozzi
t al., 1997; Perry et al., 1998; Wood et al., 1998). Nedd4
regulates sodium ion transport by interacting with an
epithelial sodium channel (ENaC), which plays an essen-
tial role in the control of salt and fluid homeostasis in the
kidney and the colon (Rossier and Palmer, 1992). The
channel is composed of three subunits (abg), each of
hich contains a proline-rich region at the carboxyl-
erminus, which is regulated by ubiquitination (Staub et
l., 1997). Liddle’s syndrome in humans, a hereditary
orm of hypertension, is caused by deletions or muta-
ions within the PY motifs of the b or g subunit of ENaC
(Shimkets et al., 1994; Hansson et al., 1995a,b; Tamura et
al., 1996). Similarly, mutations within the WW domain of
Nedd4 result in a loss of binding to the sodium channel
(Staub et al., 1996).
The ubiquitination of cell-surface receptors following
receptor activation is just being appreciated (Bonifacino
and Weissman, 1998; Hicke, 1999). The platelet-derived
growth factor receptor (PDGF), FCeRI, c-kit, c-Met, and
the T-cell receptor (TCR) are all ubiquitinated following
activation (Bonifacino and Weissman, 1998; Hicke, 1999).
Most germane to the current studies are results with the
TCR. In these studies, it was shown that receptor ubiq-
uitination was linked with tyrosine kinase activation and
phosphorylation (Cenciarelli et al., 1996). Treatment with
the tyrosine kinase inhibitor, herbimycin, resulted in an
inhibition of receptor ubiquitination (Cenciarelli et al.,
1996). Consistent with this result, it was found that treat-
ment with pervanadate, which increases cellular tyrosine
phosphorylation, enhanced receptor ubiquitination (Cen-
ciarelli et al., 1996). Also relevant to these studies is the
observation that receptor ubiquitination was not ob-
served in cells deficient for Lck, a T-cell-specific src
family tyrosine kinase (Cenciarelli et al., 1996). A link
between ubiquitination of plasma-membrane receptors
and proteasomal degradation has been shown in mam-
malian cells only for c-Met, by using the proteasome
inhibitor lactacystin (Jeffers et al., 1997). Moreover, the
ubiquitin-protein ligase responsible for ubiquitination of
cell receptors such as the TCR and c-Met has not been
determined; studies using yeast, however, have proved
more informative. Studies of yeast membrane proteins,
including both receptors and transporters, indicate that
ubiquitination is a targeting signal for endocytosis and
subsequent degradation. Most informative, studies on
the yeast uracil permease (Fur4p) (Hein et al., 1995;
Galan et al., 1996), the general amino acid permease
(Gap1p) (Hein et al., 1995), and a-factor receptor (Ste2p)
Hicke and Riezman, 1996) have revealed that the essen-
o
iial protein Rsp5 is involved in the endocytosis and deg-
adation of both permeases and the receptor. Rsp5 is a
ember of the Nedd4 family of ubiquitin-protein ligases.
The association of LMP2A with the Nedd4 ubiquitin
igases is unprecedented, but may provide clues to the
egulation of B-cell signal transduction in cells infected
ith EBV. The function of the Nedd4 family of ubiquitin
igases remains unclear in cells of lymphocyte origin.
IP4 was isolated as a binding-protein for atrophin-1,
hich is expressed widely in human brain tissues. Atro-
hin-1 is essential to normal neurological function, since
utations in atrophin-1 cause a progressive neurode-
enerative disorder (Wood et al., 1998). The murine ho-
molog of AIP4 is Itchy. Although a specific binding-pro-
tein for Itchy is still unknown, mice with a specific mu-
tation in the itchy locus develop a unique spectrum of
immunological diseases (Hustad et al., 1995; Perry et al.,
1998), although the biochemical nature of this phenotype
is unknown. WWP1/AIP5 and WWP2/AIP2 were identified
by their ability to bind the PY motifs in WBP-1 and WBP-2
(Pirozzi et al., 1997), although their functions are also
unknown.
Considering the role of Nedd4 and Rsp5, which ap-
pear to regulate membrane channels, receptors, and
transporters through ubiquitination, and the rapid ubiq-
uitination of diverse cellular receptors such as the TCR
and PDGF receptor following receptor activation,
LMP2A-associated ubiquitin-protein ligases are likely to
direct the degradation of membrane-associated proteins.
Indeed rapid degradation of LMP2A and the membrane-
associated tyrosine kinase Lyn were demonstrated in
this study. In this regard, LMP2A appears to play a role
as an adapter protein, recruiting enzymes like the Nedd4
family ubiquitin ligases and substrates that are to be
ubiquitinated like Lyn in an LMP2A-dependent fashion
(Fig. 7). This mechanism is similar to the function of
papillomavirus E6 that recruits cellular E6-AP and p53,
resulting in the degradation of p53. Lyn binds to LMP2A
via tyrosine residue 112 and is essential for the consti-
tutive LMP2A phosphorylation detected in LCLs (Frueh-
ling et al., 1998). Lyn-dependent phosphorylation allows
ther PTKs to bind specific sites within the LMP2A ami-
o-terminal cytoplasmic tail (Fruehling et al., 1998). The
yk PTK specifically binds to the LMP2A ITAM at tyrosine
esidues 74 and 85 (Fruehling and Longnecker, 1997).
yk bound to LMP2A becomes constitutively phosphor-
lated and is unable to participate in BCR-initiated signal
ransduction (Fruehling and Longnecker, 1997). Interest-
ngly, we showed in this study that Lyn but not Syk is
apidly degraded in LMP2A-expressing cells, although
MP2A constitutively binds to both Lyn and Syk. Future
tudies will need to directly demonstrate the ubiquitina-
ion of Lyn, LMP2A, and other possible targets. In addi-
ion, by constructing specific mutations in the PY domain
f LMP2A in the EBV viral genome, the functional signif-
cance of the ubiquitin ligase association with LMP2A
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188 IKEDA ET AL.can be tested directly. Finally, as in many past cases with
viral proteins, the association of LMP2A with ubiquitin
ligases may provide insight into the basic regulation of
normal BCR signal transduction. By associating with the
Lyn and Syk protein tyrosine kinase, LMP2A is integrated
into normal B-cell signal transduction and as such may
be providing initial evidence that ubiquitin protein li-
gases are important for the regulation of normal signal
transduction through the BCR.
MATERIALS AND METHODS
Cell lines
All cell lines were maintained in RPMI 1640 medium
supplemented with 10% fetal bovine serum (FBS), 1000
U/ml penicillin, and 1000 mg/ml streptomycin (complete
PMI 1640 medium). BJAB and Ramos are EBV-negative
-lymphoma cell lines. Raji is an EBV-positive B-lym-
hona cell line. Jurkat and HPB.ALL are acute T-cell
eukemia cell lines. M12 is a mouse B-cell line. All cell
ines were obtained from ATCC (Rockville, MD). BJAB cell
ines expressing LMP2A were generated by infection
ith retrovirus stocks, using a previously described
MP2A retroviral expression construct (Longnecker and
ieff, 1990). Retrovirus stocks were made by transient
ransfection of the Phoenix cell line (Kinsella and Nolan,
996). The resulting stocks were used to infect BJAB
ells, which were then plated in 96-well plates 12 h
ostinfection to isolate clonal cell lines. Cell lines were
elected in 400 U/ml hygromycin.
ntibodies
The anti-Lyn mouse monoclonal antibody was pur-
FIG. 7. Model for LMP2A specific degradation of LMP2A-associated
proteins such as Lyn. LMP2A recruits Nedd4-like ubiquitin protein
ligases to the PY motif, resulting in the ubiquitination of LMP2A and
certain LMP2A-associated proteins, which results in their rapid degra-
dation and the subsequent down-modulation of B-cell signal transduc-
tion. Interestingly, some LMP2A-associated proteins may not be af-
fected, such as the Syk protein tyrosine kinase.hased from Transduction Laboratories. The anti-Syk
ouse monoclonal antibody (4D10) was purchased fromanta Cruz Biotechnology. The anti-FLAG mouse mono-
lonal antibody (M2) and biotinylated anti-FLAG mouse
onoclonal antibody (Bio M2) were purchased from
igma. The anti-influenza virus hemagglutinin (HA1)
pitope mouse monoclonal antibody (HA.11) and rat
onoclonal antibody (3F10) were purchased from
AbCO and Boehringer-Mannheim, respectively. The
nti-LMP2A rat monoclonal antibody (14B7) has been
reviously described (Fruehling et al., 1996). The anti-b-
ubulin mouse monoclonal antibody was purchased
rom Amersham. The anti-PI 3-kinase p85 rabbit anti-
erum was purchased from Upstate Biotechnology. All
orseradish peroxidase (HRP)-conjugated secondary an-
ibodies were purchased from Amersham. The NeutrAvi-
in-HRP was purchased from Pierce.
lasmids
A series of vectors for the expression of LMP2A GST-
usion proteins were constructed. Primers corresponding
o the 59 and 39 ends of the amino-terminal cytosolic
omain of LMP2A flanked by 59 BglII or 39 EcoRI restric-
ion sites were used to amplify the LMP2A gene fragment
y PCR. The amplified fragments were subcloned in-
rame into pGEX-2TK between the BamHI and EcoRI
ites (Pharmacia). pLMP2A expresses the HA epitope-
agged LMP2A (LMP2A-HA) from early SV40 promoter
Fruehling et al., 1998). Mutations in the proline-rich mo-
ifs of LMP2A were introduced into the LMP2A GST-
usion expression vectors by PCR-based site-directed
utagenesis. All plasmids and constructed mutations
ere confirmed by restriction endonuclease digestion
nd DNA sequencing.
ST fusion proteins and binding assay
GST fusion proteins were expressed in Escherichia
oli C600lon cells and purified with glutathione agarose
y standard protocol (Nakano et al., 1994). BJAB cells
1 3 107 cells) were labeled with 1 mCi [35S]methionine-
cysteine for 24 h in 5 ml of methionine and cysteine-free
RPMI 1640 medium (Sigma) supplemented with 5% com-
plete RPMI 1640 medium and 10% FBS. Labeled cells
were washed twice with 1X PBS and lysed in 1 ml of lysis
buffer (50 mM Tris–HCl, pH 7.5; 150 mM NaCl; 2 mM
EDTA; 1% Triton X-100; 10 mM NaF; 0.5 mM phenylmeth-
ylsulfonyl fluoride; 1 mM Na3VO4; 10 mg/ml pepstatin; 10
mg/ml leupeptin). The LMP2A GST-fusion proteins bound
to glutathione–agarose (20 ml) were incubated with la-
beled cell lysate (1 3 106 cells), which was diluted
10-fold in lysis buffer at 4°C overnight. Proteins bound to
the LMP2A GST-fusion proteins were then separated on
SDS–PAGE and visualized by autoradiography.
Microsequence analysis of proteins
9An 8-liter culture of BJAB cells (4 3 10 cells) were
collected and lysed in 100 ml of lysis buffer. Cell lysates
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189LMP2A PY MOTIF-INTERACTING PROTEINwere incubated with 1 ml of glutathione agarose immo-
bilized with the LMP2A1–119 GST-fusion protein. Pro-
teins bound to LMP2A were separated on SDS–PAGE
and stained with Coomassie brilliant blue. Correspond-
ing protein bands were excised and digested proteolyti-
cally. Obtained peptides were separated by a single
microcapillary reverse-phase HPLC run directly coupled
to a nanoelectrospray ionization source of an ion-trap
mass spectrometer (mLC/MS/MS). Acquired spectra of
ndividual sequences were correlated with known se-
uences using the algorithm Sequest. The sequence
nalysis was performed at the Harvard Microchemistry
acility.
DNAs cloning
A cDNA library array derived from human spleen
Origene Technologies Inc.) was screened by PCR
mplification with specific primers for AIP4 (sense:
9-GAGCCAACAGAGACAATAGG-39; antisense: 59-GT-
TTTGTCGGCGGCAGAGA-39) or WWP2 (sense: 59-AA-
ACTGGGAAGCGCATTGG-39; antisense: 59-ACCCGA-
TGTCTGTGCGTCC-39) to isolate a full-length cDNA
or each protein. The FLAG-epitope (DYKDDDDK) was
dded to the 59 ends of the AIP4 or WWP2 gene by
CR, and ligated in sense orientation into the
cDNA3.1 expression vector downstream of cytomeg-
lovirus promoter (Invitrogen).
ransfection
BJAB cells (1 3 107 cells) were transfected in 0.4 ml
omplete RPMI 1640 medium with 20 mg of either the
AIP4 or WWP2 expression vectors and 20 mg of the
LMP2A expression vector. Vector controls were included
where applicable. Cells were pulsed once with a Gene
Pulser (Bio-Rad) at 210 V and 960 mF capacitance in a
0.4-cm electrode gap cuvette and immediately diluted in
10 ml complete RPMI 1640 medium. After 24 h incuba-
tion, cells were lysed in 1 ml of lysis buffer and used for
further analysis.
Pulse-labeling of proteins
A total of 1 3 107 cells were labeled with 0.4 mCi
35S]methionine-cysteine for 1 h in 2 ml of methionine and
cysteine-free RPMI 1640 medium supplemented with 5%
dialyzed FCS and 300 mg/ml glutamine. Following the 1 h
pulse-labeling, the [35S]methionine-cysteine was re-
moved and the cells were incubated in complete RPMI
1640 medium for relevant times.
Immunoprecipitation
A total of 1 3 107 cells were harvested and lysed in 1
ml of lysis buffer. Cleared lysates were incubated with
the appropriate antibody (3 mg of anti-FLAG antibody
M2], 0.25 mg of anti-Lyn antibody, or 5 mg of anti-HAantibody [HA.11]) for 1 h at 4°C. Immune complexes were
captured with 20 ml of Protein A or G–Sepharose (Phar-
acia) for 1 h at 4°C. After three washes with lysis buffer,
mmunoprecipitated proteins were resuspended in 2X
DS–PAGE sample buffer and subjected to SDS–PAGE.
mmunoblotting
For soluble cell extracts, a total of 1 3 107 cells were
ysed in 1 ml of lysis buffer, cleared by centrifugation, and
ixed with 2X SDS–PAGE sample buffer. Proteins were
esolved by SDS–PAGE, transferred to Immobilon, and
locked with 4% skim milk at room temperature for 1 h.
embranes were incubated in 4% skim milk in TBST (10
M Tris–HCl, pH 7.5; 150 mM NaCl; 0.05% Tween 20)
ith primary antibody (anti-HA antibody [3F10] at 1:2000
ilution, anti-FLAG antibody [Bio M2] at 1:1000 dilution,
nti-LMP2A antibody at 1:10,000 dilution, anti-Lyn anti-
ody at 1:1000 dilution, anti-Syk antibody at 1:1000 dilu-
ion, anti-PI 3 kinase antibody at 1:4000 dilution, or anti-
ubulin antibody at 1:4000 dilution) for 1 h, and then with
ppropriate secondary antibody at 1:2000 dilution for 1 h.
ollowing incubation, the membranes were washed with
BST, and the blot was visualized using ECL (Amer-
ham).
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